Roche CEO points to higher future drug prices in Switzerland after US deal
Roche CEO points to higher future drug prices in Switzerland after US deal
Source link
Similar Posts
1 Canadian Stock Ready to Surge In 2025
First Quantum Minerals (TSX:FM) is shaping up to be a standout stock for 2025, and its prospects are tightly interwoven with the optimistic outlook for copper. With a rating of “outperform” and a target price of $24, analysts believe that First Quantum is well-positioned to benefit from both macroeconomic trends and company-specific developments. Copper, often…
Comex: Physical Silver Demand Keeps The Market In Backwardation
Oselote/iStock via Getty Images The CME Comex is the Exchange where futures are traded for gold, silver, and other commodities. The CME also allows futures buyers to turn their contracts into physical metal through delivery. You can find more detail on the CME Source link
Ahead of Market: 10 things that will decide stock market action on Monday
Equity benchmark indices Sensex and Nifty advanced for the fourth straight session on Friday, supported by buying in blue-chips ICICI Bank and Reliance Industries amid fresh foreign fund inflows. The BSE Sensex climbed 303 points to reclaim the 84,000 level and settle at 84,058. During the day, it jumped 333 points to 84,089. Here’s how…
AMG Yacktmann Fund Q4 2025 Commentary (YACKX)
AMG Yacktman Fund Q4 2025 Commentary Source link
